Sheffield leads UK trial into stem cell treatment for severe scleroderma

Sheffield Teaching Hospitals NHS Foundation Trust has become the only site in the UK to open a groundbreaking international trial which could revolutionise care for people living with a rare and ...

Scleroderma Market to Reach US$ 4,103.07 Million by 2033 as Biologics, Targeted Therapies, and Early Diagnosis Transform Patient Outcomes | Report …

According to DataM Intelligence, "The Scleroderma Market Size reached US$ 2,384.73 million in 2024 and is expected to expand ...
The Lancet

Hedgehog signalling: on the way to curing idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible lung disease associated with poor quality of ...
Scientific Research Publishing

Actinic Damage: The Major Cause of Skin Aging ()

Tanaka, Y. , Aganahi, A. and Parker, R. (2025) Actinic Damage: The Major Cause of Skin Aging. Journal of Cosmetics, ...